Moreover, another three potential drugs, phloretin, cucurbitacin B, and bimosiamose, which are the inhibitors of AQP9, STAT3, and SELL, respectively, have been reported to improve neurologic deficits after rat cerebral ischemia by reducing oxidative stress (70–72). Here, SELL is linked to brain ischemia.